Your browser doesn't support javascript.
loading
Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors.
Gibaja, V; Shen, F; Harari, J; Korn, J; Ruddy, D; Saenz-Vash, V; Zhai, H; Rejtar, T; Paris, C G; Yu, Z; Lira, M; King, D; Qi, W; Keen, N; Hassan, A Q; Chan, H M.
Afiliação
  • Gibaja V; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Shen F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Harari J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Korn J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Ruddy D; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Saenz-Vash V; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Zhai H; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Rejtar T; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Paris CG; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Yu Z; China Novartis Institutes for BioMedical Research, Shanghai, China.
  • Lira M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • King D; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Qi W; China Novartis Institutes for BioMedical Research, Shanghai, China.
  • Keen N; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Hassan AQ; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Chan HM; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
Oncogene ; 35(5): 558-66, 2016 Feb 04.
Article em En | MEDLINE | ID: mdl-25893294

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alelos / Complexo Repressor Polycomb 2 / Linfoma / Mutação / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alelos / Complexo Repressor Polycomb 2 / Linfoma / Mutação / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article